Health Products

Novamoxin (2016-08-18)

· Published by Health Canada · Official notice

Details

Alert type: Drug Recall
Category: Drugs
Issue: Product Safety
Audience: General Public, Healthcare Professionals, Hospitals
Department: Health Canada
Hazard classification: Type III
Get told about the next health product recall.

We email or text you when Canada issues a recall that matches what you watch: a brand, a product, an allergen. Most never make the news.

Get health product recall alerts

CA$3.99/mo · cancel anytime

Products

Lot or serial numberCompaniesBrand nameDosage formDIN, NPN, DIN-HIMStrength
35434290A
Recalling Firm
Teva Canada Ltd.
30 Novopharm Court
Toronto
M1B 2K9
Ontario
CANADA
Marketing Authorization Holder
Teva Canada Ltd.
30 Novopharm Court
Toronto
M1B 2K9
Ontario
CANADA
NovamoxinGranules for suspensionDIN 00452149125 mg / 5 mL

Introduction

Affected Products

Novamoxin

Reason

Product does not meet the stability specification for homogeneity

Depth of distribution

Pharmacies and Wholesalers
Alberta, British Columbia, Manitoba, Saskatchewan, New Brunswick, Newfoundland, Ontario
and Quebec.
Get told about the next health product recall.
Get health product recall alerts

CA$3.99/mo · cancel anytime